Rhinal Therapeutics
PrivateLast Round
Angel
Aug 7, 2025
Total Funding Raised
$20,000
Company Overview
Rhinal Therapeutics is a healthtech company that develops nasal device technology for the delivery of intranasal dry powder GLP-1 treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhinal Therapeutics Comparables
Compare Rhinal Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therakind Ltd | 83% | |
| Zeteo Biomedical | 82% | |
| AptarGroup | 72% |
Rhinal Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Aug 7, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2025
$20K raised in an angel round.
Rhinal Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rhinal Therapeutics's valuation, stock price, and market status.
Is Rhinal Therapeutics a public or private company?
Rhinal Therapeutics is a private company.
What is the current stock price of Rhinal Therapeutics?
Rhinal Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Rhinal Therapeutics worth (valuation)?
Valuation information for Rhinal Therapeutics is not publicly available.
Can I buy Rhinal Therapeutics stock?
Rhinal Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rhinal Therapeutics's last funding round?
Rhinal Therapeutics's most recent funding round was Angel on August 7, 2025.
Who are the main investors in Rhinal Therapeutics?
Investor information for Rhinal Therapeutics is not publicly disclosed.
Will Rhinal Therapeutics IPO soon?
No public IPO plans have been announced for Rhinal Therapeutics.
How can I track Rhinal Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rhinal Therapeutics's secondary market activity and sign up for updates.